收藏切换
Mechanism of intestinal microbiota disorder inducing obesity development
收藏切换
Wen-qi XU1, 2, Sheng WANG1, 2, Yan WANG1, 2, Qi-bing MEI1, 2, 3, Li LIU1, 2, 3, *
World Clinical Drug | 2018, 39(6) : 417 - 421
Less
收藏切换
World Clinical Drug | 2018, 39(6): 417-421
• Review •
Mechanism of intestinal microbiota disorder inducing obesity development
Full
Wen-qi XU1, 2, Sheng WANG1, 2, Yan WANG1, 2, Qi-bing MEI1, 2, 3, Li LIU1, 2, 3, *
Affiliations
  • 1.China State Institute of Pharmaceutical Industry, Shanghai 200040
  • 2.State Key Laboratory of New Drug and Pharmaceutical Process, Shanghai Institute of Pharmaceutical Industry, Shanghai 200437
  • 3.Shanghai Professional and Technical Service Center for Biological Material Druggability Evaluation, Shanghai 200437, China
Published: 2018-06-10 doi: 10.13683/j.wph.2018.06.013
Outline
收藏切换

Normal intestinal microbiota is involved in many important physiological processes such as the nutrient metabolism, immune regulation and nervous system development. However, the change of genes and environmental factors can cause intestinal microecological imbalances, which can lead to a variety of physiological activity disorders including obesity development and related metabolic syndromes. The obesity patients have a higher risk of suffering from diabetes, cardiovascular disease, and cancer. In the past, the cognition of obesity mainly revolved around the mechanism of fat metabolism. However, the reversal of intestinal microbiota dysbiosis can effectively improve obesity and related metabolic diseases. Now, the mechanism of intestinal microbiota disorder affected obesity development is still not very clear. This article aims to review the research progress on the mechanism of intestinal microbiota disorder in obesity development, to provide a reference for obesity improvement.

intestinal microbiota disorder  /  obesity  /  pathogenesis
许文琦, 王生, 王艳, 梅其炳, 刘莉. 肠道菌群失调诱导肥胖发生发展的机制研究进展. 世界临床药物, 2018 , 39 (6) : 417 -421 . DOI: 10.13683/j.wph.2018.06.013
Wen-qi XU, Sheng WANG, Yan WANG, Qi-bing MEI, Li LIU. Mechanism of intestinal microbiota disorder inducing obesity development[J]. World Clinical Drug, 2018 , 39 (6) : 417 -421 . DOI: 10.13683/j.wph.2018.06.013
Year 2018 volume 39 Issue 6
10
2
Cite this Article
BibTeX
Article Info
doi: 10.13683/j.wph.2018.06.013
  • Receive Date:2018-03-11
  • Online Date:2026-11-18
  • Published:2018-06-10
Article Data
Affiliations
History
  • Received:2018-03-11
  • Revised:2018-04-27
Funding
Affiliations
    1.China State Institute of Pharmaceutical Industry, Shanghai 200040
    2.State Key Laboratory of New Drug and Pharmaceutical Process, Shanghai Institute of Pharmaceutical Industry, Shanghai 200437
    3.Shanghai Professional and Technical Service Center for Biological Material Druggability Evaluation, Shanghai 200437, China
References
Share
https://castjournals.cast.org.cn/joweb/sjlcyw/EN/10.13683/j.wph.2018.06.013
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT